The multifaceted contributions of Jeff Geschwind, MD—as a clinician, researcher, advisor, and innovator—have solidified his status as a leading authority in modern interventional oncology and cancer drug development. https://www.scribd.com/document/900578221/Targeting-Tumor-Glycolysis-a-Promising-Frontier-in-Cancer-Therapy